These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 9263996)
1. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996 [TBL] [Abstract][Full Text] [Related]
2. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Shankland SJ; Hugo C; Coats SR; Nangaku M; Pichler RH; Gordon KL; Pippin J; Roberts JM; Couser WG; Johnson RJ Kidney Int; 1996 Oct; 50(4):1230-9. PubMed ID: 8887282 [TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G; Hunter T; Ruoslahti E Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134 [TBL] [Abstract][Full Text] [Related]
4. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197 [TBL] [Abstract][Full Text] [Related]
5. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Shankland SJ; Pippin J; Flanagan M; Coats SR; Nangaku M; Gordon KL; Roberts JM; Couser WG; Johnson RJ Kidney Int; 1997 Apr; 51(4):1088-99. PubMed ID: 9083274 [TBL] [Abstract][Full Text] [Related]
7. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090 [TBL] [Abstract][Full Text] [Related]
9. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ; Chang CY; Lin JK Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329 [TBL] [Abstract][Full Text] [Related]
10. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury. Park SK; Kim W; Lee CH; Koh GY Nephron; 2000 Nov; 86(3):306-14. PubMed ID: 11096288 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
14. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451 [TBL] [Abstract][Full Text] [Related]
15. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S; Lowe M; Herliczek TW; Keyomarsi K Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471 [TBL] [Abstract][Full Text] [Related]
16. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest. Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428 [TBL] [Abstract][Full Text] [Related]
17. Effects of cyclin D1 overexpression on G1 progression-related events. Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597 [TBL] [Abstract][Full Text] [Related]
18. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914 [TBL] [Abstract][Full Text] [Related]
19. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425 [TBL] [Abstract][Full Text] [Related]
20. Cyclin E-CDK2 is a regulator of p27Kip1. Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]